FDA leaders are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny.
FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny. @arthurallen202.bsky.social has the details: kffhealthnews.org/news/article ...
-- KFF Health News (@kffhealthnews.org) Sep 12, 2025 at 11:22 AM
[image or embed]
Drudge Retort Headlines
Sen. Mark Kelly Faces Pentagon Investigation (122 comments)
Nearly 1 in 3 Expect to Slip Into Debt This Holiday Season (89 comments)
Comey, James Cases Dismissed (48 comments)
World Losing Climate War; Fragile Cop30 Deal Keeps Up Fight (25 comments)
Republicans Are Fleeing Remaining Trump Term (21 comments)
DOGE 'doesn't exist' with Eight Months Left on its Charter (17 comments)
Trump to Immediately End Protections for Minnesota Somalis (17 comments)
Two Texas Men Indicted in Plot to Take over Haitian Isle for Slaves (14 comments)
Mess over Leaked US-Russia Peace Plan: Ideal Putin Scenario (14 comments)
North Carolina Republicans Worry About Trump Immigration Raids (12 comments)